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Purpose: To determine the clinical outcomes of women and men 
with nonobstructive coronary artery disease (CAD) with 
coronary computed tomographic (CT) angiography data 
in patients who were similar in terms of CAD risk factors, 
angina typicality, and CAD extent and distribution.
Materials and 
Methods:
Institutional review board approval was obtained for all 
participating sites, with either informed consent or waiver 
of informed consent. In a prospective international mul-
ticenter cohort study of 27 125 patients undergoing coro-
nary CT angiography at 12 centers, 18 158 patients with 
no CAD or nonobstructive (,50% stenosis) CAD were 
examined. Men and women were propensity matched for 
age, CAD risk factors, angina typicality, and CAD extent 
and distribution, which resulted in a final cohort of 11 462 
subjects. Nonobstructive CAD presence and extent were 
related to incident major adverse cardiovascular events 
(MACE), which were inclusive of death and myocardial 
infarction and were estimated by using multivariable Cox 
proportional hazards models.
Results: At a mean follow-up 6 standard deviation of 2.3 years 6 
1.1, MACE occurred in 164 patients (0.6% annual event 
rate). After matching, women and men experienced iden-
tical annualized rates of myocardial infarction (0.2% vs 
0.2%, P = .72), death (0.5% vs 0.5%, P = .98), and MACE 
(0.6% vs 0.6%, P = .94). In multivariable analysis, non-
obstructive CAD was associated with similarly increased 
MACE for both women (hazard ratio: 1.96 [95% confi-
dence interval {CI}: 1.17, 3.28], P = .01) and men (haz-
ard ratio: 1.77 [95% CI: 1.07, 2.93], P = .03).
Conclusion: When matched for age, CAD risk factors, angina typi-
cality, and nonobstructive CAD extent, women and men 
experience comparable rates of incident mortality and 
myocardial infarction.
q RSNA, 2014
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the smaller sample sizes, more formal 
analyses inclusive of propensity match-
ing of men and women have not been 
performed. We hypothesized that non-
obstructive disease at coronary CT 
angiography confers similar prognosis 
in men and women when matched for 
preexisting CAD risk factors, symptom 
status, and extent of disease. To test 
our hypothesis, we assessed the clinical 
outcomes of women and men with non-
obstructive CAD by using coronary CT 
angiography findings from a large inter-
national registry.
Materials and Methods
Eligibility Criteria
The design of the Coronary CT Angi-
ography Evaluation For Clinical Out-
comes: An International Multicenter, or 
CONFIRM, registry has been described 
in detail (14). Institutional review board 
extent of obstructive CAD and superior 
left ventricular function identified with 
invasive coronary angiography in women 
versus men (7–9). In keeping with 
these invasively derived findings, we ob-
served with noninvasive coronary com-
puted tomographic (CT) angiography a 
higher hazard ratio (HR) for mortality 
in women with three-vessel or left main 
obstructive CAD compared with men 
(10).
Recent pooled analyses of women 
from large randomized trials have sug-
gested that women with nonobstructive 
CAD at invasive coronary angiography 
also have a worsened prognosis com-
pared with those with normal coro-
nary arteries (9), a finding that may be 
partially explained by the influence of 
revascularization rates on downstream 
outcomes. In addition, published data 
from the Women’s Health Initiative 
document suggest that women with 
nonspecific or atypical chest pain ex-
hibit a twofold greater risk for nonfatal 
MI (11). Furthermore, Women’s Ische-
mia Syndrome Evaluation (WISE) data 
have demonstrated increased overall 
rates of mortality in women with chest 
pain and no obstructive CAD, suggest-
ing that women may be at increased 
risk, despite atypical symptoms and the 
absence of obstructive disease (12).
Among stable patients suspected 
of having CAD, identification of non-
obstructive CAD with coronary CT 
angiography enables prognostication 
of future all-cause mortality and major 
adverse cardiovascular events (MACE) 
(10). In other studies, investigators 
have attempted to look at the relative 
effect of nonobstructive disease identi-
fied with coronary CT angiography on 
downstream event rates (13); however, 
these have been limited by generally 
small sample sizes and, as a result, 
limited events. In addition, owing to 
Published online before print
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Advances in Knowledge
 n The extent and pattern of coro-
nary artery disease (CAD) may 
vary between men and women; 
however, when matched for car-
diac risk factors, symptom 
status, and extent of nonobstruc-
tive disease identified with coro-
nary CT angiography, men and 
women exhibit the same rates of 
major adverse cardiac events.
 n Nonobstructive CAD confers an 
increased risk of myocardial in-
farction and death in both men 
and women across varied stratifi-
cations of cardiovascular risk and 
symptom status (hazard ratio 
[HR] for women: 1.77 [95% con-
fidence interval {CI}: 1.07, 
2.93]; HR for men: 1.96 [95% 
CI: 1.17, 3.28]).
 n Women without atherosclerosis 
at coronary CT angiography have 
a similar excellent clinical prog-
nosis to that of men, irrespective 
of the type or presence of symp-
toms (annualized event rate of 
0.3% vs 0.3% [not significant]).
 n When stratified by the presence 
or absence of symptoms and by 
angina typicality, there were no 
observed differences in the rela-
tionship between nonobstructive 
disease and mortality for women 
versus men (not significant).
Implication for Patient Care
 n Our data suggest that men and 
women with comparable risk and 
disease extent have a comparable 
prognosis, regardless of symptom 
nature and status, and should 
likely be treated accordingly.
Prior investigators have identified substantial disparities in health outcomes according to patient sex 
in individuals with clinically significant 
coronary artery disease (CAD), with 
higher mortality in women compared 
with that in men with acute myocardial 
infarction (MI) (1–3). As compared 
with men, women are more likely to 
die of sudden death prior to arrival at 
the hospital (4). Further, women with 
symptomatic CAD require more fre-
quent hospitalizations for both angina 
and heart failure and report lower qual-
ity of life scores, when compared with 
their male counterparts (5,6). These 
sex-based disparities in CAD outcomes 
persist, despite a lower incidence and 
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the least amount of coronary artery 
motion were chosen for analysis. Re-
constructed data were evaluated by 
highly experienced readers (level III 
equivalent and/or board certified in 
coronary CT angiography) (J.L., with 
8 years of experience; M.A.M., with 
8 years of experience; D.S.B., with 12 
years of experience; M.J.B., with 15 
years of experience; F.C., with 9 years 
of experience; T.Q.C., with 12 years of 
experience; a nonauthor, with 9 years 
of experience; A.J.D., with 11 years of 
experience; B.J.W.C., with 9 years of 
experience; M.H., with 8 years of expe-
rience; J.H., with 9 years of experience; 
G.M.F., with 9 years of experience; 
R.C.C., with 10 years of experience; 
T.C.V., with 9 years of experience; 
K.M.C., with 7 years of experience; 
and G.L.R., 9 years of experience) by 
using all necessary postprocessing tech-
niques to determine the presence of 
CAD in any visible segment at least 2 
mm in diameter. In all individuals, ir-
respective of image quality, every arte-
rial segment was scored in an intent-to-
diagnose fashion. If a coronary artery 
segment was uninterpretable despite 
these multiple techniques, the segment 
that could not be evaluated was scored 
similarly to the most proximal segment 
that could be evaluated.
All participating sites used stan-
dardized anatomic segmental analysis 
for the coronary CT angiography inter-
pretation. For this analysis, each of the 
16 segments was coded for the pres-
ence of no stenosis and mild stenosis 
(defined as .0% but ,50%). Patients 
defined as having a stenosis of at least 
50% were not included in this series. 
As a measure of overall coronary artery 
plaque extent and distribution, the seg-
ment involvement score (SIS) was cal-
culated as the total number of coronary 
artery segments that exhibited plaque 
(minimum score = 0, maximum score 
= 16) (17). All sites performed the 
coronary CT angiography interpreta-
tions prospectively at the time of image 
acquisition.
Follow-up Methods
The methods for follow-up have been 
described previously (14). Participants 
no chest pain. At each site, symptom 
category was prospectively ascertained 
through written questionnaire or in-
terview by a physician or allied health 
professional.
Clinical history was ascertained 
through patient interview and clini-
cal questionnaire. A prior diagnosis of 
CAD was defined as a documented MI 
or coronary revascularization. Hyper-
tension, diabetes mellitus, and hyper-
lipidemia were defined as previous di-
agnoses of these diseases or treatment 
with medications targeted at manag-
ing them. Current cigarette smokers 
or those who quit smoking within 3 
months of testing were established to 
have a positive smoking history. A clin-
ically significant family history of CAD 
was defined as that occurring in a prior 
relative less than 65 years of age in 
women and less than 55 years of age 
in men.
Coronary CT Angiography Image 
Acquisition and Interpretation Procedures
We used standardized protocols, de-
fined by the Society of Cardiovascular 
Computed Tomography, for image ac-
quisition (16). Coronary CT angiogra-
phy was performed by using multiple 
scanner platforms (Light Speed VCT, 
GE Healthcare, Milwaukee, Wis; So-
matom Definition CT, Siemens, Erlan-
gen, Germany; and Somatom Definition 
Flash CT, Siemens). Timing bolus or 
automated bolus tracking at the proxi-
mal ascending aorta was used to deter-
mine the time from contrast material 
injection to optimal coronary artery en-
hancement. Contrast material (80–140 
mL) was injected, and whole-volume 
image acquisition was completed in a 
single breath hold. The scanning pa-
rameters were 64 3 0.625-mm or 64 3 
0.750-mm collimation and tube voltage 
of 100 or 120 kVp, and the tube current 
was assigned on the basis of body size 
and scanner platform.
Helical or axial scanning data were 
obtained with retrospective or pro-
spective electrocardiogram gating, re-
spectively. Acquired image data were 
initially reconstructed in mid-diastole 
(always) and end-systole (when avail-
able), and images from the phase with 
approval was obtained for all participat-
ing sites, with either informed consent 
or waiver of informed consent. As a 
prospective, observational, multicenter 
registry, adults at least 18 years of age 
were prospectively enrolled at each of 
the 12 enrolling centers between 2005 
and 2009. Enrolled patients included 
prospective referrals of those under-
going at least 64–detector row coro-
nary CT angiography. All centers had 
institutional review board approval for 
patient enrollment, including follow-up 
methods. For this analysis, only those 
patients without known CAD and with 
either no or mild disease (defined as 
stenosis of up to 50% of the artery di-
ameter) at coronary CT angiography 
were included. Among 27 125 consec-
utive patients referred to the partici-
pating centers for coronary CT angiog-
raphy, 8967 were excluded for having 
known disease or for having obstruc-
tive disease identified with coronary CT 
angiography, leaving a total of 18 158 
subjects identified in the remaining 
group with a stenosis grading of none 
(n = 10 101) or mild (.0% but ,50% 
stenosis, n = 8057) at coronary CT an-
giography. Men and women were then 
matched in 1:1 fashion on the basis of 
preexisting CAD risk factors, angina 
typicality, and nonobstructive CAD ex-
tent by the number of segments with 
coronary lesions. The final matched co-
hort comprised 11 462 patients.
CAD Risk Factor and Angina Typicality 
Ascertainment
Prior to coronary CT angiography, de-
mographic data and a focused history 
of CAD risk factors and the nature of 
chest pain were obtained from each 
patient. Chest pain was categorized 
according to the classic criteria for 
angina pectoris (15). Patients with 
typical angina experienced substernal, 
jaw, and/or arm pressure–like pain that 
consistently occurred with exertion and 
consistently resolved within 15 minutes 
of rest and/or use of nitroglycerin. Pa-
tients with atypical angina experienced 
two of three of these characteristics. 
Patients with nonanginal chest pain ex-
perienced one or none of these char-
acteristics. Asymptomatic patients had 
CARDIAC IMAGING: Sex-based Prognostic Implications of Nonobstructive Coronary Artery Disease Leipsic et al
396 radiology.rsna.org n Radiology: Volume 273: Number 2—November 2014
risk-adjusted HR for the prediction of 
mortality in patients with nonobstruc-
tive CAD as compared with no CAD was 
1.58 (95% CI: 1.06, 2.37) (P = .03). 
The annual MI rate was 0.2% (95% CI: 
0.1%, 0.2%) overall and 0.08% (95% 
CI: 0.04%, 0.1%) and 0.3% (95% CI: 
0.2%, 0.5%) for patients with no CAD 
and nonobstructive CAD, respectively 
(P , .0001). The risk-adjusted HR for 
MI in patients with nonobstructive CAD 
as compared with no CAD was 3.24 
(95% CI: 1.56, 6.73) (P = .002). The 
annual MACE (MI and death) rate was 
0.6% (95% CI: 0.5%, 0.7%) overall and 
0.3% (95% CI: 0.3%, 0.4%) and 1.1% 
(95% CI: 0.9%, 1.4%) for patients with 
no CAD and nonobstructive CAD, re-
spectively (P , .0001). The risk-adjust-
ed HR for MACE in patients with non-
obstructive CAD as compared with no 
CAD was 1.84 (95% CI: 1.28, 2.63) (P 
= .001) (Fig 1).
Sex-stratified Prognostic Implications for 
MACE (MI and Death) in Nonobstructive 
CAD versus Absence of CAD after 
Propensity Matching
Annual rates of MACE (MI and death) 
based on normal arteries and nonob-
structive CAD were similar for women 
(0.3% [95% CI: 0.2%, 0.5%] and 
1.2% [95% CI: 0.9%, 1.5%], respec-
tively) and men (0.3% [95% CI: 0.2%, 
P value less than .05 was considered to 
indicate a significant difference.
Results
Baseline Clinical Characteristics of the 
Study Population
Tables 1 and 2 provide clinical char-
acteristics, demographics, and pretest 
clinical risk assessment of the overall 
cohort and the final propensity-matched 
cohort. The propensity score resulted 
in successfully matching 5731 (65.1%) 
of the 8808 women to 5731 men (mean 
caliper difference, 0.006 6 0.004). The 
standardized differences were all less 
than 0.1, indicating acceptable match-
ing. Within the propensity-matched co-
hort of 11 462 subjects, there were 164 
cases (1.4%) of MI and death, with 37 
experiencing MI, 120 deaths, and seven 
cases of both MI and death.
Prognostic Implications of Nonobstructive 
CAD versus Normal Coronary Arteries 
after Propensity Matching
The annual mortality rate was 0.5% 
(95% confidence interval [CI]: 0.4%, 
0.6%) overall and 0.3% (95% CI: 0.2%, 
0.4%) and 0.9% (95% CI: 0.7%, 1.1%) 
for patients with no CAD and nonob-
structive CAD, respectively, at coro-
nary CT angiography (P , .0001). The 
were followed up with the primary end 
point of MI and death. For participat-
ing U.S. centers, the national death 
index was queried for all patients. In 
non-U.S. sites, all patients, their rela-
tives, or primary care physicians were 
interviewed to ascertain vital status. As 
there is substantial misclassification of 
cause of death, we base our analysis 
on all-cause mortality (18), and MI 
ascertainment and adjudication were 
performed at sites by means of direct 
interview, telephone contact, or review 
of medical records. For the purposes of 
this analysis, only death and MI were 
considered as events. Coronary revas-
cularization (90 days) was censored 
(72 patients) to eliminate the risk of 
sex-based treatment bias affecting the 
clinical event rate.
Statistical Analysis
Continuous variables were compared 
by using two-sample t tests or the Wil-
coxon rank-sum test if nonnormally 
distributed. Categorical variables were 
compared by using the Pearson x2 test 
or the Fisher exact for small cell counts 
less than six. Survival curves were vi-
sualized by using Kaplan-Meier curves 
and were compared by using log-rank 
tests. Annual event rates were derived 
by dividing the number of events by 
person-years. Predictors of MACE, MI, 
and death were assessed by using Cox 
regression modeling, after verifying the 
assumption of proportional hazards 
with Schoenfeld residuals. Men and 
women were matched for risk factors 
(age, hypertension, high cholesterol, 
diabetes, smoking, family history, chest 
pain symptom presence, and log SIS, 
where the SIS was log-transformed 
toward normality and then back-trans-
formed into original units for purposes 
of reporting; matching was done by us-
ing the 1:1 Mahalanobis nearest-neigh-
bor algorithm within a caliper of 0.01) 
and evaluated by using standardized 
differences (19,20). A post hoc analysis 
with our observed MACE event rates 
show 80% power to detect a minimum 
HR of 1.5 with 11 462 patients and 1.7 
in men or women subgroups. All data 
were analyzed by using Stata version 
11.2 software (www.statacorp.com). A 
Table 1
Baseline Clinical Characteristics, Demographics, and Pretest Clinical Risk 
Assessment of the Study Population (Unmatched Cohort)
Parameter All (n = 18 158) Women (n = 8808) Men (n = 9350) P Value
Age (y)* 55.6 6 12.5 57.4 6 12.3 53.8 6 12.5 ,.0001
Asymptomatic patients 5530 (30.4) 2180 (24.8) 3350 (35.8) ,.001
Hypertension 8296 (45.7) 4372 (49.6) 3924 (42.0) ,.001
Hyperlipidemia 9232 (50.8) 4577 (52.0) 4655 (49.8) .003
Diabetes 2182 (12.0) 1135 (12.9) 1047 (11.2) ,.001
Current smoker 3001 (16.5) 1253 (14.2) 1748 (18.7) ,.001
Family history 6209 (34.2) 3256 (37.0) 2953 (31.6) ,.001
Log (SIS + 1)* 0.52 6 0.66 0.41 6 0.61 0.63 6 0.69 ,.001
Pretest likelihood of CAD .001
 ,15% 7417 (40.8) 3717 (42.2) 3700 (39.6) .95
 15%–85% 7423 (40.9) 3776 (42.9) 3647 (39.0) .07
 .85% 1257 (6.9) 570 (6.5) 687 (7.3) ,.001
Note.—Data are numbers of patients, unless indicated otherwise. Numbers in parentheses are percentages.
* Data are means 6 standard deviations.
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Sex-based Relationship of Coronary CT 
Angiography Findings and Mortality
No differences in mortality were ob-
served between men and women in 
the setting of normal coronary CT an-
giography findings (HR = 1.09 [range, 
0.6–2.0], P = .78; annual event rate = 
0.3% [95% CI: 0.2%, 0.4%] in both, 
P = .87) or in the presence of nonob-
structive disease (HR = 1.01 [range, 
0.7–1.6], P = .95) (annual event rate = 
0.9% [95% CI: 0.7%, 1.2%] and 0.8% 
[95% CI: 0.6%, 1.1%] in women and 
0.5%] and 1.1% [95% CI: 0.8%, 
1.4%], respectively). For women, 
propensity-matched HR for nonob-
structive CAD versus no CAD was 
1.96 (95% CI: 1.17, 3.28) (P = .01) 
and for men was 1.77 (95% CI: 1.07, 
2.93) (P = .03) (Table E1 [online]). 
For women, propensity-matched HR 
for risk of MI in nonobstructive CAD 
versus no CAD was 3.04 (95% CI: 
1.13, 8.17) (P = .03) and for men was 
3.54 (95% CI: 1.18, 10.58) (P = .02) 
(Table E1 [online]).
Table 2
Baseline Clinical Characteristics, Demographics, and Pretest Clinical Risk Assessment of the Study Population (Matched Cohort with 
Standardized Differences)
Parameter All (n = 11 462) Women (n = 5731) Men (n = 5731) Standardized Differences P Value
Age (y)*† 55.1 6 12.3 55.5 6 12.5 54.7 6 12.0 0.06 .0001
Asymptomatic patients† 3849 (33.6) 1934 (33.7) 1915 (33.4) 0.007 .71
Hypertension† 5197 (45.3) 2603 (45.4) 2594 (45.3) 0.003 .87
Hyperlipidemia† 5867 (51.2) 2984 (52.1) 2883 (50.3) 0.04 .06
Diabetes† 1372 (12.0) 723 (12.6) 649 (11.3) 0.04 .03
Current smoker† 2052 (17.9) 1044 (18.2) 1008 (17.6) 0.02 .38
Family history† 3829 (33.4) 1952 (34.1) 1877 (32.8) 0.03 .14
No. of involved segments*† 0.60 6 0.89 0.62 6 0.91 0.59 6 0.86 0.03 .35
Note.—Data are numbers of patients, unless indicated otherwise. Numbers in parentheses are percentages.
* Data are means 6 standard deviations.
† Matching factors.
Figure 1
Figure 1: Graph demonstrates 3-year Kaplan-Meier event-free survival for no CAD versus nonobstructive 
disease in the propensity-matched cohort.
men, respectively; P = .89) (Fig 2). 
Men exhibit an increasing risk with 
higher SIS: 1–2 segments, HR = 2.71 
(range, 1.61–4.57), P , .001; 3–6 seg-
ments, HR = 3.99 (range, 2.24–7.09), 
P , .001; and more than six segments, 
HR = 6.16 (range, 2.15–17.66), P = 
.001. Women exhibit similarly ele-
vated hazard for death when stratified 
by SIS: 1–2 segments, HR = 2.80 (range, 
1.65–4.76), P , .001; 3–6 segments, 
HR = 4.22 (range, 2.41–7.40), P , 
.001; and more than six segments, HR 
= 4.72 (range, 1.65–13.54), P = .004.
Sex-based Relationship of Coronary CT 
Angiography Findings and All-Cause 
Mortality and MI Stratified by Symptom 
Status and Type
When stratified by the presence or ab-
sence of symptoms and angina typical-
ity, there were no observed differences 
in the relationship between nonobstruc-
tive disease and mortality for women 
versus men (not significant) (Tables E2 
and E3 [online]).
Effect of Plaque Morphology on All-Cause 
Mortality and MI Stratified by Sex
In a subgroup of patients with noncal-
cified plaque (Table E3 [online]), the 
risk of MACE prognosis in men was not 
significantly different compared with 
women (unadjusted HR = 1.96 [95% 
CI: 0.90, 4.28], P = .09; risk-adjusted 
HR = 1.91 [95% CI: 0.87, 4.20], P = 
.11). This similar relationship between 
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differential effect of nonobstructive CAD 
on adverse prognosis when examining 
mortality, MI, or both. Of equal impor-
tance, the absence of CAD at coronary 
CT angiography conferred an excellent 
prognosis for both women and men and 
did not differ according to sex. Impor-
tantly, in our analysis, we attempted 
to advance our understanding of the 
prognostic importance of nonobstruc-
tive disease in men and women through 
propensity matching of subjects on the 
basis of CAD risk, symptoms, and ex-
tent of disease in an attempt to isolate 
sex as the only distinguishing variable. 
In addition, in our analysis, we explored 
a historically large number of subjects 
and events in an attempt to better un-
derstand the effect of sex on clinical out-
comes after coronary CT angiography.
Our data build on those of prior stud-
ies in which investigators attempted to 
address the question of the effect of sex 
on prognosis. Some of these prior stud-
ies have been conflicting in their results. 
Min and colleagues showed compara-
ble clinical outcomes between men and 
women but did not focus on nonobstruc-
tive disease and were limited to all-cause 
mortality as an end point, without data 
on MI (10). Shaw et al published results 
that conflicted with our data and sug-
gested that men and women have dispa-
rate clinical outcomes (13). Importantly, 
however, the aforementioned study was 
an analysis of a small cohort with limited 
events and was methodologically differ-
ent than our study, without matching 
of men and women, and did not focus 
on nonobstructive disease. Through our 
careful matching of men and women, we 
feel we are able to explore the potential 
effect of sex on prognosis, as all other 
potential drivers of events have been ac-
counted for, leaving only differences in 
patient sex.
Over the past 2 decades, there has 
been growing evidence that the patho-
physiology of CAD in women and men 
may be different (7–9,11,12). Microvas-
cular dysfunction has been implicated as 
a potential cause of these differences, 
with microvascular dysfunction said to 
be more common in women than in 
men, with resultant higher event rates 
and a greater burden of chest pain 
nonobstructive CAD would serve as a 
potentially important variable for pre-
diction of prognosis according to sex. 
In our prospective multicenter interna-
tional study, we observed a prognostic 
importance for all patients with nonob-
structive CAD wherein rates of incident 
mortality and MI were heightened for 
patients with CAD as compared with 
patients without. Yet, among women 
and men who were similar according to 
age, CAD risk factors, and nonobstruc-
tive CAD extent, we did not observe a 
men and women holds true for calcified 
plaque (unadjusted HR = 0.74 [95% CI: 
0.46, 1.22], P = .24; risk-adjusted HR 
= 0.84 [95% CI: 0.51, 1.38], P = .49) 
and partially noncalcified plaque (unad-
justed HR = 0.80 [95% CI: 0.45, 1.80], 
P = .43; risk-adjusted HR = 0.70 [95% 
CI: 0.40, 1.25], P = .23).
Discussion
In the present study, we aimed to ex-
amine whether the extent of epicardial 
Figure 2
Figure 2: Graphs demonstrate Kaplan-Meier event-free survival curves in a matched population, matched 
on the basis of age, symptoms, risk factors, and log SIS. ACM = all-cause mortality.
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downstream event rates to those of men, 
despite being older. Finally, downstream 
treatment decisions—including medica-
tion use and lifestyle modifications—are 
unknown, and, thus, the possibility of 
sex-based treatment biases cannot be 
excluded.
In conclusion, when matched for 
age, CAD risk factors, angina typical-
ity, and nonobstructive epicardial CAD 
extent, women and men experience 
comparable rates of incident mortal-
ity, MI, and MACE. The absence of any 
coronary atherosclerosis at coronary 
CT angiography afforded a remarkably 
low annual mortality (0.3%) and MI 
(0.08%) rate, irrespective of sex.
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mild CAD, particularly in the absence 
of luminal encroachment (21). Unlike 
invasive angiography, CT is able to not 
only allow traditional angiographic mea-
surement of stenosis severity, but also 
demonstrate atherosclerotic plaque and 
coronary arterial wall features in a fash-
ion similar to that of intravascular ultra-
sonography (21–23). In this regard, we 
observed an excellent prognosis for both 
sexes in the setting of normal coronary 
CT angiography findings—a result that 
was independent of symptom status—
suggesting a prognostic utility of normal 
coronary CT angiography findings that 
can be used to clarify risk in a sex-neu-
tral manner. Additionally, our data sug-
gest that while the cause of the different 
patterns and severity of chest pain and 
the apparent discordance between the 
severity of coronary disease and symp-
toms in women remain unclear, normal 
coronary angiography findings without 
atherosclerosis confer a similar prog-
nosis in men and women, regardless of 
symptom status.
This study is not without limitations. 
First, it was composed of individuals 
undergoing clinically indicated coronary 
CT angiography studies and was obser-
vational in nature. As a result, inherent 
biases associated with selection and as-
certainment cannot be excluded. Thus, 
our study findings, while provocative, 
cannot allow for cause-and-effect con-
clusions. Second, direct comparisons 
of the present study findings cannot be 
made with those of prior investigations, 
such as those observed in the WISE 
study. In our study, we specifically ex-
amined patients undergoing noninva-
sive testing—given the higher number 
of individuals suspected of having CAD 
who were undergoing this type of work-
up—whereas prior studies have primar-
ily focused on individuals undergoing 
invasive evaluation, yielding a popula-
tion that may differ in disease extent 
and pathophysiology. Third, while our 
propensity matching was extensive and 
careful, there remained differences in 
age between the sexes in our analysis. 
Importantly, women were older, which 
if anything would result in a bias toward 
worsened outcomes as compared with 
the men, but they in fact had very similar 
and symptoms, despite the absence of 
obstructive disease at invasive angiog-
raphy. It has also been suggested that 
these differences may result in paradox-
ical frequent (atypical) symptoms and 
adverse clinical outcomes (11,12). There 
are a number of theories as to why mi-
crovascular dysfunction may be more 
common in women, including vascular 
inflammation, risk factor clustering, vas-
cular remodeling, and hormonal alter-
ations (11,12,20). To date, however, the 
mechanisms of these adverse prognostic 
findings have not yet been elucidated.
In this regard, our data may clarify 
prior study findings in which CAD was 
examined in invasive catheter angiogra-
phy studies, wherein the prognosis of 
nonobstructive CAD has been reported 
as differing between men and women 
(8,9,11,12). In the WISE studies, in-
vestigators have reported that approxi-
mately one-half of symptomatic women 
without obstructive CAD at catheter 
angiography have microvascular coro-
nary dysfunction that results in ische-
mia and that microvascular dysfunction 
is associated with adverse cardiovas-
cular prognosis (8,9,11,12). Our data 
strengthen the WISE conclusions that 
extent and distribution of epicardial 
nonobstructive CAD may not be a sig-
nificant contributor to sex-based differ-
ences in adverse clinical outcomes, as 
was observed in women and men who 
were similar in age, CAD risk factors, 
and coronary CT angiography–identi-
fied CAD extent. In fact, when matched 
for important characteristics, differ-
ences in MI and death did not exist.
Importantly, the adverse prognosis 
associated with microvascular dysfunc-
tion in the WISE cohorts has been doc-
umented even in the setting of normal 
invasive coronary angiography findings, 
whereas we observed a similarly excel-
lent prognosis among both women and 
men with normal coronary arteries at 
coronary CT angiography. This apparent 
discordance between the data presented 
herein and past publications likely re-
flects differences in the technique used 
for coronary artery assessment. It is 
well established that coronary CT an-
giography is more sensitive than cath-
eter angiography for the detection of 
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